Academic Journal
Construction of novel 10 signatures in diabetic retinopathy construction of model based on WGCNA: Mechanism of action of RPL3 and MRPL16 protein.
| Title: | Construction of novel 10 signatures in diabetic retinopathy construction of model based on WGCNA: Mechanism of action of RPL3 and MRPL16 protein. |
|---|---|
| Authors: | Xiaojing S; Department of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China., Li M; Department of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China. Electronic address: fymali@dmu.edu.cn. |
| Source: | International journal of biological macromolecules [Int J Biol Macromol] 2025 Jan; Vol. 286, pp. 138235. Date of Electronic Publication: 2024 Nov 30. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0003 (Electronic) Linking ISSN: 01418130 NLM ISO Abbreviation: Int J Biol Macromol Subsets: MEDLINE |
| Imprint Name(s): | Publication: Amsterdam : Elsevier Original Publication: Guildford, Eng., IPC Science and Technology Press. |
| MeSH Terms: | Diabetic Retinopathy*/genetics , Diabetic Retinopathy*/metabolism , Diabetic Retinopathy*/pathology , Ribosomal Proteins*/genetics , Ribosomal Proteins*/metabolism , Ribosomal Protein L3*/genetics , Ribosomal Protein L3*/metabolism , Mitochondrial Proteins*/genetics , Mitochondrial Proteins*/metabolism , Gene Regulatory Networks*, Computational Biology/methods ; Humans ; Animals ; Gene Expression Profiling ; Gene Expression Regulation ; Male |
| Abstract: | Diabetic retinopathy is a common microvascular complication in diabetic patients, which can lead to blindness in severe cases. At present, although a variety of treatment methods are available, the pathological mechanism has not been fully elucidated. As ribosomal proteins, RPL3 and MRPL16 play important roles in cell metabolism and protein synthesis, but their specific roles in diabetic retinopathy are unclear. This study aims to construct new features of diabetic retinopathy by WGCNA method, and reveal the mechanism of RPL3 and MRPL16 protein in diabetic retinopathy, so as to provide new ideas for the early diagnosis and treatment of diabetic retinopathy. The study collected retinal tissue samples from patients with diabetic retinopathy and used high-throughput sequencing techniques to obtain gene expression data. Gene expression data were analyzed by WGCNA method to construct the characteristic module of diabetic retinopathy. On this basis, the genes significantly associated with diabetic retinopathy were screened out, and the mechanism of action of RPL3 and MRPL16 proteins in diabetic retinopathy was studied through bioinformatics analysis and experimental verification. Through WGCNA analysis, we successfully constructed a characteristic module of diabetic retinopathy and screened out genes significantly associated with the disease. Further studies have shown that RPL3 and MRPL16 proteins are up-regulated in diabetic retinopathy and play key roles in cell metabolism and protein synthesis. Through in vitro experiments and animal model verification, we found that the abnormal expression of RPL3 and MRPL16 proteins is closely related to the pathological process of diabetic retinopathy. (Copyright © 2024 Elsevier B.V. All rights reserved.) |
| Competing Interests: | Declaration of competing interest The authors declare no competing interests. |
| Contributed Indexing: | Keywords: Construction of new 10 features; Diabetes; Mechanism of protein action; Retinopathy; WGCNA: RPL3 and MRPL16 |
| Substance Nomenclature: | 0 (Ribosomal Proteins) 0 (Ribosomal Protein L3) 0 (RPL3 protein, human) 0 (Mitochondrial Proteins) |
| Entry Date(s): | Date Created: 20241201 Date Completed: 20250426 Latest Revision: 20250517 |
| Update Code: | 20260130 |
| DOI: | 10.1016/j.ijbiomac.2024.138235 |
| PMID: | 39617243 |
| Database: | MEDLINE |
| FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=45CF964D96D32DD75FFD&Show=Object Text: Availability: 0 CustomLinks: – Url: https://www.doi.org/10.1016/j.ijbiomac.2024.138235? Name: ScienceDirect (all content) (s7799221) Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 39617243 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Construction of novel 10 signatures in diabetic retinopathy construction of model based on WGCNA: Mechanism of action of RPL3 and MRPL16 protein. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xiaojing+S%22">Xiaojing S</searchLink>; Department of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Department of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China. Electronic address: fymali@dmu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227909578%22">International journal of biological macromolecules</searchLink> [Int J Biol Macromol] 2025 Jan; Vol. 286, pp. 138235. <i>Date of Electronic Publication: </i>2024 Nov 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>7909578 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0003 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201418130%22">01418130 </searchLink><i>NLM ISO Abbreviation: </i>Int J Biol Macromol <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Publication</i>: Amsterdam : Elsevier<br /><i>Original Publication</i>: Guildford, Eng., IPC Science and Technology Press. – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Diabetic+Retinopathy%22">Diabetic Retinopathy*</searchLink>/<searchLink fieldCode="MM" term="%22Diabetic+Retinopathy+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Diabetic+Retinopathy%22">Diabetic Retinopathy*</searchLink>/<searchLink fieldCode="MM" term="%22Diabetic+Retinopathy+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Diabetic+Retinopathy%22">Diabetic Retinopathy*</searchLink>/<searchLink fieldCode="MM" term="%22Diabetic+Retinopathy+pathology%22">pathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Ribosomal+Proteins%22">Ribosomal Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22Ribosomal+Proteins+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Ribosomal+Proteins%22">Ribosomal Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22Ribosomal+Proteins+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Ribosomal+Protein+L3%22">Ribosomal Protein L3*</searchLink>/<searchLink fieldCode="MM" term="%22Ribosomal+Protein+L3+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Ribosomal+Protein+L3%22">Ribosomal Protein L3*</searchLink>/<searchLink fieldCode="MM" term="%22Ribosomal+Protein+L3+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Mitochondrial+Proteins%22">Mitochondrial Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22Mitochondrial+Proteins+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Mitochondrial+Proteins%22">Mitochondrial Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22Mitochondrial+Proteins+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Gene+Regulatory+Networks%22">Gene Regulatory Networks*</searchLink><br /><searchLink fieldCode="MH" term="%22Computational+Biology%22">Computational Biology</searchLink>/<searchLink fieldCode="MH" term="%22Computational+Biology+methods%22">methods</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Animals%22">Animals</searchLink> ; <searchLink fieldCode="MH" term="%22Gene+Expression+Profiling%22">Gene Expression Profiling</searchLink> ; <searchLink fieldCode="MH" term="%22Gene+Expression+Regulation%22">Gene Expression Regulation</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Diabetic retinopathy is a common microvascular complication in diabetic patients, which can lead to blindness in severe cases. At present, although a variety of treatment methods are available, the pathological mechanism has not been fully elucidated. As ribosomal proteins, RPL3 and MRPL16 play important roles in cell metabolism and protein synthesis, but their specific roles in diabetic retinopathy are unclear. This study aims to construct new features of diabetic retinopathy by WGCNA method, and reveal the mechanism of RPL3 and MRPL16 protein in diabetic retinopathy, so as to provide new ideas for the early diagnosis and treatment of diabetic retinopathy. The study collected retinal tissue samples from patients with diabetic retinopathy and used high-throughput sequencing techniques to obtain gene expression data. Gene expression data were analyzed by WGCNA method to construct the characteristic module of diabetic retinopathy. On this basis, the genes significantly associated with diabetic retinopathy were screened out, and the mechanism of action of RPL3 and MRPL16 proteins in diabetic retinopathy was studied through bioinformatics analysis and experimental verification. Through WGCNA analysis, we successfully constructed a characteristic module of diabetic retinopathy and screened out genes significantly associated with the disease. Further studies have shown that RPL3 and MRPL16 proteins are up-regulated in diabetic retinopathy and play key roles in cell metabolism and protein synthesis. Through in vitro experiments and animal model verification, we found that the abnormal expression of RPL3 and MRPL16 proteins is closely related to the pathological process of diabetic retinopathy.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.) – Name: Abstract Label: Competing Interests Group: Ab Data: Declaration of competing interest The authors declare no competing interests. – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Construction of new 10 features; Diabetes; Mechanism of protein action; Retinopathy; WGCNA: RPL3 and MRPL16 – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Ribosomal Proteins)<br />0 (Ribosomal Protein L3)<br />0 (RPL3 protein, human)<br />0 (Mitochondrial Proteins) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20241201 <i>Date Completed: </i>20250426 <i>Latest Revision: </i>20250517 – Name: DateUpdate Label: Update Code Group: Date Data: 20260130 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.ijbiomac.2024.138235 – Name: AN Label: PMID Group: ID Data: 39617243 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=39617243 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ijbiomac.2024.138235 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 138235 Subjects: – SubjectFull: Computational Biology methods Type: general – SubjectFull: Humans Type: general – SubjectFull: Animals Type: general – SubjectFull: Gene Expression Profiling Type: general – SubjectFull: Gene Expression Regulation Type: general – SubjectFull: Male Type: general – SubjectFull: Diabetic Retinopathy genetics Type: general – SubjectFull: Diabetic Retinopathy metabolism Type: general – SubjectFull: Diabetic Retinopathy pathology Type: general – SubjectFull: Ribosomal Proteins genetics Type: general – SubjectFull: Ribosomal Proteins metabolism Type: general – SubjectFull: Ribosomal Protein L3 genetics Type: general – SubjectFull: Ribosomal Protein L3 metabolism Type: general – SubjectFull: Mitochondrial Proteins genetics Type: general – SubjectFull: Mitochondrial Proteins metabolism Type: general – SubjectFull: Gene Regulatory Networks Type: general Titles: – TitleFull: Construction of novel 10 signatures in diabetic retinopathy construction of model based on WGCNA: Mechanism of action of RPL3 and MRPL16 protein. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xiaojing S – PersonEntity: Name: NameFull: Li M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1879-0003 Numbering: – Type: volume Value: 286 Titles: – TitleFull: International journal of biological macromolecules Type: main |
| ResultId | 1 |